The race for a covid-19 vaccine: a brand opportunity and risk for the entire pharmaceutical sector

The big news from Pfizer on its covid-19 vaccine candidate has brought optimism to many this week. In our latest opinion column we consider the brand dimensions of this breakthrough – for Pfizer and the wider pharmaceutical industry.


Get unlimited access to all WTR content